These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 38367859)

  • 41. Vasopressin-Induced Hyponatremia in Patients With Aneurysmal Subarachnoid Hemorrhage: A Case Series and Literature Review.
    Subba H; Riker RR; Dunn S; Gagnon DJ
    J Pharm Pract; 2023 Jun; 36(3):689-694. PubMed ID: 34674580
    [No Abstract]   [Full Text] [Related]  

  • 42. Cerebrospinal fluid untargeted metabolomic profiling of aneurysmal subarachnoid hemorrhage: an exploratory study.
    Lu AY; Damisah EC; Winkler EA; Grant RA; Eid T; Bulsara KR
    Br J Neurosurg; 2018 Dec; 32(6):637-641. PubMed ID: 30585503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival and outcome in patients with aneurysmal subarachnoid hemorrhage in Glasgow coma score 3-5.
    Lashkarivand A; Sorteberg W; Rosseland LA; Sorteberg A
    Acta Neurochir (Wien); 2020 Mar; 162(3):533-544. PubMed ID: 31980948
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of intrathecal milrinone injection via lumbar catheter on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Koyanagi M; Fukuda H; Lo B; Uezato M; Kurosaki Y; Sadamasa N; Handa A; Chin M; Yamagata S
    J Neurosurg; 2018 Mar; 128(3):717-722. PubMed ID: 28298035
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-Dose Intravenous Heparin Infusion After Aneurysmal Subarachnoid Hemorrhage is Associated With Decreased Risk of Delayed Neurological Deficit and Cerebral Infarction.
    Kole MJ; Wessell AP; Ugiliweneza B; Cannarsa GJ; Fortuny E; Stokum JA; Shea P; Chryssikos T; Khattar NK; Crabill GA; Schreibman DL; Badjatia N; Gandhi D; Aldrich EF; James RF; Simard JM
    Neurosurgery; 2021 Feb; 88(3):523-530. PubMed ID: 33269390
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal neuropsychological assessment after aneurysmal subarachnoid hemorrhage and its relationship with delayed cerebral ischemia: a prospective Swiss multicenter study.
    Stienen MN; Germans MR; Zindel-Geisseler O; Dannecker N; Rothacher Y; Schlosser L; Velz J; Sebök M; Eggenberger N; May A; Haemmerli J; Bijlenga P; Schaller K; Guerra-Lopez U; Maduri R; Beaud V; Al-Taha K; Daniel RT; Chiappini A; Rossi S; Robert T; Bonasia S; Goldberg J; Fung C; Bervini D; Maradan-Gachet ME; Gutbrod K; Maldaner N; Neidert MC; Früh S; Schwind M; Bozinov O; Brugger P; Keller E; Marr A; Roux S; Regli L; ;
    J Neurosurg; 2022 Dec; 137(6):1742-1750. PubMed ID: 35535839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and functional outcome analysis of ventriculoperitoneal shunt placement for hydrocephalus within the critical phase of possible delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.
    Jost JN; Irmak Y; Grüter B; Tortora A; Marbacher S; Musahl C; Schubert GA; Andereggen L; Wanderer S
    Neurosurg Rev; 2023 Nov; 46(1):302. PubMed ID: 37973641
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful weaning versus permanent cerebrospinal fluid diversion after aneurysmal subarachnoid hemorrhage: post hoc analysis of a Swiss multicenter study.
    El-Garci A; Zindel-Geisseler O; Dannecker N; Rothacher Y; Schlosser L; Zeitlberger A; Velz J; Sebök M; Eggenberger N; May A; Bijlenga P; Guerra-Lopez U; Maduri R; Beaud V; Starnoni D; Chiappini A; Rossi S; Robert T; Bonasia S; Goldberg J; Fung C; Bervini D; Gutbrod K; Maldaner N; Früh S; Schwind M; Bozinov O; Neidert MC; Brugger P; Keller E; Germans MR; Regli L; Hostettler IC; Stienen MN; ;
    Neurosurg Focus; 2023 Apr; 54(4):E3. PubMed ID: 37004134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term functional prognosis of patients with aneurysmal subarachnoid hemorrhage treated with rehabilitation combined with hyperbaric oxygen: Case-series study.
    Wang Y; Gao Y; Lu M; Liu Y
    Medicine (Baltimore); 2020 Jan; 99(3):e18748. PubMed ID: 32011457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modafinil for poststroke patients: A systematic review.
    Pacheco RL; Latorraca COC; da Silva LDGM; Ferreira DBGM; Fernandes CAA; Hosni ND; Cabrera Martimbianco AL; Vianna Pachito D; Riera R
    Int J Clin Pract; 2019 Feb; 73(2):e13295. PubMed ID: 30444561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High Angiopoietin-1 levels predict a good functional outcome within 72 h of an aneurysmal subarachnoid hemorrhage: A prospective study from a single center.
    Wang Y; Tian Y; Wang D; Wei H; Zhao Z; Jiang R; Yue S; Zhang J
    J Neurol Sci; 2015 Sep; 356(1-2):72-6. PubMed ID: 26208799
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Significance of fluctuations in serum sodium levels following aneurysmal subarachnoid hemorrhage: an exploratory analysis.
    Eagles ME; Tso MK; Macdonald RL
    J Neurosurg; 2019 Aug; 131(2):420-425. PubMed ID: 30117765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum Alkaline Phosphatase Level is Associated with Angiographic Vasospasm, Delayed Cerebral Ischemia-Caused Clinical Deterioration, and Functional Outcome After Aneurysmal Subarachnoid Hemorrhage.
    Zhu Y; Jiang H; Li Y; Weng Y; Xu K; Zhou L; Lin H; Sun T; Cheng D; Shen J; Zeng J; Ye D; Wang D; Zhan R
    Neurocrit Care; 2019 Dec; 31(3):466-475. PubMed ID: 31016639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Use of Modafinil in the Intensive Care Unit.
    Gajewski M; Weinhouse G
    J Intensive Care Med; 2016 Feb; 31(2):142-5. PubMed ID: 25716122
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predictive Factors for Rebleeding After Aneurysmal Subarachnoid Hemorrhage: Rebleeding Aneurysmal Subarachnoid Hemorrhage Study.
    van Donkelaar CE; Bakker NA; Veeger NJ; Uyttenboogaart M; Metzemaekers JD; Luijckx GJ; Groen RJ; van Dijk JM
    Stroke; 2015 Aug; 46(8):2100-6. PubMed ID: 26069261
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of clazosentan on cerebral vasospasm-related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients.
    Endo H; Hagihara Y; Kimura N; Takizawa K; Niizuma K; Togo O; Tominaga T
    J Neurosurg; 2022 Dec; 137(6):1707-1717. PubMed ID: 35364589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Value of a Structural Brain MRI Score in the Acute Phase of Aneurysmal Subarachnoid Hemorrhage: A Pilot Study.
    Nelson SE; Piran P; Hua J; Sigmon A; Weiner C; Sair HI; Suarez JI; Stevens RD
    Neurocrit Care; 2021 Oct; 35(2):501-505. PubMed ID: 33751446
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute systemic erythropoietin therapy to reduce delayed ischemic deficits following aneurysmal subarachnoid hemorrhage: a Phase II randomized, double-blind, placebo-controlled trial. Clinical article.
    Tseng MY; Hutchinson PJ; Richards HK; Czosnyka M; Pickard JD; Erber WN; Brown S; Kirkpatrick PJ
    J Neurosurg; 2009 Jul; 111(1):171-80. PubMed ID: 19344224
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of short-term ε-aminocaproic acid treatment on patients undergoing endovascular coil embolization following aneurysmal subarachnoid hemorrhage.
    Malekpour M; Kulwin C; Bohnstedt BN; Radmand G; Sethia R; Mendenhall SK; Weyhenmeyer J; Hendricks BK; Leipzig T; Payner TD; Shah MV; Scott J; DeNardo A; Sahlein D; Cohen-Gadol AA
    J Neurosurg; 2017 May; 126(5):1606-1613. PubMed ID: 27315025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of a revised Glasgow Coma Score scale in predicting long-term outcome of poor grade aneurysmal subarachnoid hemorrhage patients.
    Starke RM; Komotar RJ; Kim GH; Kellner CP; Otten ML; Hahn DK; Michael Schmidt J; Sciacca RR; Mayer SA; Sander Connolly E
    J Clin Neurosci; 2009 Jul; 16(7):894-9. PubMed ID: 19375327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.